Bioinfra Co., Ltd. engages in research. The company conducts testing of generic drugs, phase 1 clinical trials of drugs, trial for approval, immunoassays, and pharmaceutical quality inspections The company was founded on May 23, 2007 and is headquartered in Yong-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company